Midazolam
Pronunciation: mid-AY-zoh-lam.
- Generic name
- midazolam
- Drug class
- Benzodiazepine sedative
- Form
- Injection, nasal spray, oromucosal solution
- Route
- Injection, nasal spray, or oromucosal solution depending on the product
- Legal status
- Prescription-only; controlled-medicine rules vary by country and formulation
Prescription medicine; many products are for clinical use
Trade names by country: United States · United Kingdom · Canada · Australia · Nepal · New Zealand
Australia: Midazolam Viatris (8), Pfizer (Australia) Midazolam Injection (9) · Full directory
What midazolam is and how it works
Midazolam is a benzodiazepine that depresses central nervous system activity. It is used in supervised procedural or critical-care settings and, in some countries and formulations, as prescribed rescue treatment for seizure clusters or prolonged convulsive seizures. (1) (2) (3) (5)
The exact indication, route, dose, and monitoring depend on the individual product and country. This page does not give a universal dose or a self-treatment plan. Follow the specific prescription and product leaflet.
Mechanism of action: how midazolam works
Midazolam is a short-acting benzodiazepine with sedative, anxiolytic, amnestic, muscle-relaxant, and anticonvulsant effects. (1) (5)
What midazolam is used for
Procedural sedation
Injection may be used by trained clinicians before or during procedures or anaesthesia, with monitoring and resuscitation capability. (1) (2)
Critical-care sedation
Specific intravenous products may be used for sedation of intubated, mechanically ventilated patients in critical care. (1)
Prescribed seizure rescue
Certain nasal or oromucosal products are prescribed for specific seizure emergencies; caregivers need product-specific training and a seizure action plan. (3) (5)
Before taking midazolam
Do not take / not appropriate for
- Do not use if you have had a serious allergy to midazolam, benzodiazepines, or product ingredients. (product-label dependent) (1) (5)
- Do not use another person’s prescription or a different route/formulation as a substitute. (all countries) (3) (5)
Tell your clinician about
- Breathing problems, sleep apnoea, heart, liver, or kidney disease.
- All medicines, alcohol, opioids, sedatives, herbal products, and recreational drugs.
- Pregnancy, breastfeeding, older age, frailty, or history of substance-use disorder.
- Any prior paradoxical reaction to a benzodiazepine.
How to take midazolam
- Use only exactly as prescribed or administered by trained healthcare professionals.
- For a prescribed rescue product, ensure the caregiver follows the specific labelled instructions and seizure action plan.
- Do not drink alcohol or take unapproved sedating medicines with midazolam.
- Do not drive or operate machinery until fully recovered and your clinician says it is safe.
Procedures and hospital treatment
Injected midazolam requires trained staff, continuous appropriate monitoring, resuscitation drugs and airway equipment. Tell the team about every medicine and substance you have taken. (1)
Missed dose
Most injected uses are clinician-administered and rescue products are used only according to a plan. Do not take an extra dose or repeat a rescue dose unless your exact prescription or clinician instructs this.
All countries
Ask the prescriber or pharmacist for your product-specific missed-dose and repeat-dose instructions. (3) (5)
Overdose
Too much midazolam can cause extreme sleepiness, slowed or difficult breathing, coma, or death—especially with opioids, alcohol, or other sedatives. Call emergency services immediately if the person is difficult to wake or has breathing problems. (3) (1)
Side effects
Drowsiness and impaired coordination can occur. Respiratory effects are the key safety concern and require immediate action.
Drowsiness, memory or coordination problems
What to notice: Sleepiness, slowed thinking, unsteadiness, or temporary memory impairment.
What to do: Avoid driving, alcohol, and hazardous tasks until completely recovered. (2) (5)
Unusual agitation or behaviour
What to notice: Restlessness, agitation, involuntary movements, or unexpected behavioural change.
What to do: Seek medical advice promptly; urgent assessment may be needed. (2) (1)
Serious warnings
Breathing problems or unresponsiveness — emergency
Symptoms: Slow, shallow, difficult breathing; bluish colour; extreme sleepiness; inability to wake.
Opioids, alcohol, or other sedatives — emergency
Symptoms: Profound sedation or breathing problems may occur when combined.
Action: Do not combine unless the prescribing clinician specifically directs and monitors it. (1) (5)
Dependence and withdrawal — high caution
Symptoms: Stopping after repeated use can cause withdrawal, including seizures.
Action: Do not stop or reduce repeated use abruptly; obtain prescriber advice. (3) (1)
Interactions
| Medicine or test | Effect | Action |
|---|---|---|
| Opioids, alcohol, and other CNS depressants | Can markedly increase sedation and respiratory depression. | Tell the clinician about all substances; avoid alcohol unless specifically advised. (1) (5) |
| CYP3A4 inhibitors or inducers | May increase or decrease midazolam exposure, depending on product and medicine. | A clinician or pharmacist must check the full medicine list before use. (5) |
Pregnancy, breastfeeding, kidney/liver function, age
Pregnancy and breastfeeding
Use requires individual clinical assessment; discuss urgently with the prescriber rather than stopping a needed seizure plan without advice. (5)
Liver, kidney, heart, or respiratory disease
Effects may be prolonged or breathing risk increased; product-specific clinician assessment is necessary. (1) (5)
Children and older adults
Age-specific products and monitoring requirements apply. Do not extrapolate another person’s dose. (1) (5)
Monitoring
Before starting
- Confirm the exact product, indication, route, and seizure action plan where relevant.
- Review opioids, alcohol, sedatives, CYP3A4 modifiers, comorbidities, and airway risk.
During treatment
- Monitor alertness and breathing; in supervised injection settings, monitor respiratory and cardiovascular status.
- After rescue treatment, follow the written escalation plan and seek emergency care when indicated.
Storage
Keep prescribed rescue products in their original packaging, secured from children and others. Follow the leaflet for your exact product.
United Kingdom: Epistatus is stored in the original package to protect from light; do not refrigerate or freeze. (6)
Study the drug class: Benzodiazepines
Professional information
Clinician-facing context only. Use the exact local product label, local sedation protocol, controlled-medicine requirements, and seizure pathway.
All regions
Indication: Any midazolam use
Dose summary: No universal dose is displayed because dose and route vary by product, indication, patient factors, and monitoring setting.
Renal context: Consider renal, hepatic, respiratory, cardiac, frailty, and interacting-medicine context. (1) (5)
Hepatic guidance
Metabolism and exposure can be affected by hepatic impairment and CYP3A4 interactions; follow the exact product label.
Overdose note
Airway and ventilatory support are priorities in toxicity. Follow local emergency, toxicology, and product-specific guidance. (1) (5)
Frequently asked questions
What is midazolam used for?
midazolam is prescribed for approved indications. Always follow your healthcare provider's guidance.
What are the side effects of midazolam?
Common side effects may include gastrointestinal symptoms and headache. Serious side effects require immediate medical attention.
Can I take midazolam with other medications?
Always inform your healthcare provider about all medications you are taking, including over-the-counter products and supplements.
References
- MIDAZOLAM — midazolam hydrochloride injection, solution (Hospira) — prescribing informationDailyMed, U.S. National Library of Medicine · United States · dated 2025-07-25 · accessed 2026-07-21 · source 1
- Midazolam: MedlinePlus Drug InformationMedlinePlus, U.S. National Library of Medicine · United States · dated 2026-01-15 · accessed 2026-07-21 · source 2
- Midazolam Nasal Spray: MedlinePlus Drug InformationMedlinePlus, U.S. National Library of Medicine · United States · accessed 2026-07-21 · source 3
- Nayzilam (midazolam) nasal spray — prescribing informationDailyMed, U.S. National Library of Medicine · United States · accessed 2026-07-21 · source 4
- BUCCOLAM oromucosal solution — Summary of Product Characteristicselectronic Medicines Compendium (UK) · United Kingdom · accessed 2026-07-21 · source 5
- Epistatus oromucosal solution — patient information leafletelectronic Medicines Compendium (UK) · United Kingdom · accessed 2026-07-21 · source 6
- Midazolam injection product recordsHealth Canada Drug Product Database · Canada · accessed 2026-07-21 · source 7
- Australian Register of Therapeutic Goods midazolam product recordsTherapeutic Goods Administration · Australia · accessed 2026-07-21 · source 8
- Pfizer (Australia) Midazolam Injection ARTG recordTherapeutic Goods Administration · Australia · accessed 2026-07-21 · source 9
- Midazolam Viatris data sheetMedsafe · New Zealand · accessed 2026-07-21 · source 10
- National List of Essential Medicines Nepal and psychotropic-substance listDepartment of Drug Administration, Nepal · Nepal · accessed 2026-07-21 · source 11
- List of narcotics and psychotropic substances identified for import and useDepartment of Drug Administration, Nepal · Nepal · accessed 2026-07-21 · source 12
- Neurology and Psychiatry Subject Expert Committee recommendations, July 2024Central Drugs Standard Control Organization, India · India · accessed 2026-07-21 · source 13
Brand names by country
Single-ingredient midazolam names are shown separately by country. Product availability, strengths, and supply rules can change; combination products are not included here.
Priority countries
United States
- Nayzilam5 mg/.1mL · ucb, inc.
United Kingdom
Canada
- MIDAZOLAM INJECTION SDZ
Australia
Nepal
- Midazolam injection (11)national-essential-medicine-generic-listing · 1 mg/mL, 5 mg/mL · local product must be confirmed at dispensing
New Zealand
- Midazolam Viatris (10)current labelled brand · 1 mg/mL, 5 mg/mL · Viatris New Zealand Limited